1,230
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: HEAD AND NECK CANCER

Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland

ORCID Icon, , , , , , , , , , , , , , , , ORCID Icon & show all
Pages 541-551 | Received 07 Aug 2017, Accepted 25 Oct 2017, Published online: 17 Nov 2017

References

  • Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–619.
  • Hakulinen T, Tryggvadottir L, Gislum M, et al. Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol. 2010;49:561–577.
  • Braakhuis BJ, Visser O, Leemans CR. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol. 2009;45:e85–e89.
  • Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31:4550–4559.
  • Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol. 2012;22:128–142.
  • Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–720.
  • Allen CT, Lewis JS, Jr., El-Mofty SK, et al. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope. 2010;120:1756–1772.
  • Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2465–2472.
  • Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813–1820.
  • Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.
  • Hong AM, Dobbins TA, Lee CS, et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer. 2010;103:1510–1517.
  • Lassen P, Eriksen JG, Krogdahl A, et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol. 2011;100:49–55.
  • Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94:2967–2980.
  • Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–269.
  • Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006; 24:5630–5636.
  • Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope 2012; 122(Suppl 2):S13–S33.
  • Mehanna H, Evans M, Beasley M, et al. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130:S90–SS6.
  • Pfister DG, Spencer S, Adelstein D, et al. Head and Neck Cancers Version 2.2017. Natl Compr Canc Netw. 2017;15:761–770.
  • Samuels SE, Eisbruch A, Beitler JJ, et al. Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? Eur Arch Otorhinolaryngol. 2016; 273:2877–2894.
  • Brierley JD,K, GM, Wittekind C, editors. TNM Classification of Malignant Tumours. 8th ed. Hoboken, NJ: Wiley-Blackwell; 2016.
  • Rietbergen MM, Brakenhoff RH, Bloemena E, et al. Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol. 2013; 24:2740–2745.
  • Holsinger FC, Ferris RL. Transoral endoscopic head and neck surgery and its role within the multidisciplinary treatment paradigm of oropharynx cancer: robotics, lasers, and clinical trials. J Clin Oncol. 2015;33:3285–3292.
  • Mydlarz WK, Chan JY, Richmon JD. The role of surgery for HPV-associated head and neck cancer. Oral Oncol. 2015;51:305–313.
  • Chen AY, Schrag N, Hao Y, et al. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope. 2007;117:16–21.
  • Chen AY, Zhu J, Fedewa S. Temporal trends in oropharyngeal cancer treatment and survival, 1998–2009. Laryngoscope. 2014;124:131–138 .
  • Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM Classification of Malignant Tumours. 7th ed. Hoboken, NJ: Wiley-Blackwell; 2011.
  • Makitie AA, Pukkila M, Laranne J, et al. Oropharyngeal carcinoma and its treatment in Finland between 1995–1999: a nationwide study. Eur Arch Otorhinolaryngol. 2006;263:139–143.
  • Wang MB, Liu IY, Gornbein JA, et al. HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Head Neck Surg. 2015;153:758–769.
  • Seikaly H, Biron VL, Zhang H, et al. Role of primary surgery in the treatment of advanced oropharyngeal cancer. Head Neck. 2016;38(Suppl 1):E571–E579.
  • Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–4301.
  • Rietbergen MM, Leemans CR, Bloemena E, et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer. 2013;132:1565–1571.
  • Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362–366.
  • Holliday MA, Tavaluc R, Zhuang T, et al. Oncologic benefit of tonsillectomy in stage I and II tonsil cancer. JAMA Otolaryngol Head Neck Surg. 2013;139:362–3666.
  • Yildirim G, Morrison WH, Rosenthal DI, et al. Outcomes of patients with tonsillar carcinoma treated with post-tonsillectomy radiation therapy. Head Neck. 2010;32:473–480.
  • Loimu V, Collan J, Vaalavirta L, et al. Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin. Radiother Oncol. 2011;98:34–37.
  • Pignon JP, le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14.
  • Dahlstrom KR, Calzada G, Hanby JD, et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer. 2013;119:81–89.
  • Ward MJ, Mellows T, Harris S, et al. Staging and treatment of oropharyngeal cancer in the human papillomavirus era. Head Neck. 2015;37:1002–1013.
  • Haapaniemi A, Koivunen P, Saarilahti K, et al. Laryngeal cancer in Finland: a 5-year follow-up study of 366 patients. Head Neck. 2016;38:36–43.
  • Paximadis PA, Christensen ME, Dyson G, et al. Up-front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer. Head Neck. 2012;34:1798–1803.
  • Begg AC. Predicting recurrence after radiotherapy in head and neck cancer. Semin Radiat Oncol. 2012;22:108–118.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.